Stage IVB Rectal Cancer Terminated Phase 3 Trials for Bevacizumab (DB00112)

IndicationStatusPhase
DBCOND0028589 (Stage IVB Rectal Cancer)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00499369Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line TherapyTreatment